https://www.parentproject.it/2023/03/29/dyne-therapeutics-riceve-le-designazioni-di-farmaco-orfano-e-di-malattia-pediatrica-rara-per-dyne-251-per-il-trattamento-della-distrofia-muscolare-di-duchenne/ Insieme per fermare la Duchenne e la Becker Wed, 29 Mar 2023 07:28:07 +0000 hourly 1 https://wordpress.org/?v=6.9.4